Final issue of CCS blog for 2015

This is the final issue of the Central Clinical School blog for 2015. It's been a busy year and we wish everyone a happy, safe and restful break over the Christmas and New Year period.

The CCS blog resumes on Friday 5 Feb 2016.

Photo of the week: Prof Wendy Brown's group

Bariatric Surgery Registry (SPHPM) and Centre for Obesity Research and Education (CCS).
L-R Back row. Anna Palmer (Ethics Assistant), Brittany Smith (Customer Relationship Officer), Prof Wendy Brown (Director, Professor of Surgery, CCS), Cheryl Laurie (Research Nurse), Dianne Brown (Project Manager), Lucy Davenport (Administrative Assistant), Tiffany Tei (Summer Scholarship student)
Front row. Aileen Heal (Administrative Assistant), Jazz Padarath (Data entry assistant), Berihun Zeleke (Data entry assistant/PhD student), Margaret Anderson (Data Manager), Geri Ooi (PhD surgical trainee)

Video of the week: The FODMAP Grand Tour Down Under (animation)

Low FODMAP diet for IBS, Department of Gastroenterology, Central Clinical School

Irritable bowel syndrome (IBS) is a common functional gastrointestinal disorder affecting approximately 15% of people worldwide. Characterised by lower abdominal pain and discomfort, bloating, wind, distension and altered bowel habit (ranging from diarrhoea to constipation), the condition causes considerable discomfort and daily disruption for the sufferer. Researchers at Monash University have developed a diet strategy to manage IBS symptoms known as the low FODMAP diet. This diet is the product of extensive research which has quantified the FODMAP content of hundreds of foods, described the mechanism by which the diet works and shown that a low FODMAP diet improves symptom control in approximately three out of every four people with IBS. Join us as we go on a journey (almost like 'Fantastic Voyage'!) to understand the physiological effects of FODMAPs and the dramatic effects of a low FODMAP diet in people with IBS.

See more about Low FODMAP diet research and products at Monash:

• Website: http://bit.ly/1vXL2tQ
• App: http://bit.ly/1PKfK3Y
• Booklet: http://bit.ly/1yFzqxg
• Video link for reference:  https://youtu.be/Z_1Hzl9o5ic

Forthcoming events 2016

Dr Katherine Suter presenting
at the 2015 D.S. Rosengarten
Surgical Trainee Prize event

Central Clinical School has regular seminar series and graduate research presentations. All event notices are maintained on the CCS Events calendar. CCS staff & students can see details of both public and local events (including professional development courses, trade fairs and Graduate Research Student calendars) and deadlines, at the CCS Intranet's Announcements page.

Various departments have their own calendars. See CCS seminar index: www.med.monash.edu.au/cecs/events/seminars.html

• 21 Dec 2015: CCS Review process EOI due
• 23 Dec 2015 - 3 Jan 2016 inclusive University shutdown
• 5 Feb 2016 CCS blog resumes.
• 25 Feb 2016 CCS General Honours student orientation

Ethanol exposure and traumatic brain injury

By Dr Jodie Abramovitch

Traumatic brain injury (TBI) is an important health issue, being a major cause of death and disability worldwide. When a TBI occurs in the absence of injury to the rest of the body, it is known as an isolated TBI (iTBI). Ethanol exposure or intoxication is commonly associated with iTBI. However, following injury, the effects of ethanol in the brain are unknown.

How does ethanol affect the brain?

Researchers from the Department of Epidemiology and Preventive Medicine (DEPM) and the Department of Surgery, alongside colleagues from the Alfred Hospital’s Emergency and Trauma Centre and National Trauma Research Institute, have recently investigated the association between ethanol exposure leading to iTBI and in-hospital mortality rates.

Slowing down age-related hearing loss

By Dr Jodie Abramovitch

Loss of hearing associated with age is a leading cause of disability amongst older people. Low level inflammation may damage blood vessels within the ear, leading to hearing loss. Furthermore, hearing loss may be associated with blood vessel damage within the eye, as well as loss of cognitive function. This suggests that there may be a common underlying inflammatory cause for each of these age-related conditions.

Can aspirin reduce age-related
hearing loss? 

Aspirin is a commonly used anti-inflammatory medication. It has a known role in helping treat blood vessel diseases and can inhibit the formation of blood clots.

Monash researchers from the School of Public Health and Preventive Medicine (SPHPM) are involved in a new study called ASPREE-HEARING. This study will assess the effect of aspirin on hearing levels in patients aged 70 years and older who are involved in the ASPirin in Reducing Events in the Elderly (ASPREE) clinical trial.

Rob Medcalf delivers 2015 Barry Firkin oration

Professor Rob Medcalf delivered the Barry Firkin Oration during the Joint Haematology congress (HAA) in Adelaide on 17 Oct 2015. Dr Jennifer Curnow (President of the Australian Society for Thrombosis and Haemostasis; ASTH) is to Rob's left, presenting the artworks to Rob.